Boston Scientific
Boston Scientific Corporation, a leading name in the electromedical and electrotherapeutic apparatus manufacturing industry, is headquartered in the United States. Founded in 1979, the company has established itself as a pioneer in developing innovative medical devices that enhance patient care across various therapeutic areas, including cardiology, urology, and endoscopy.
With a strong presence in North America, Europe, and Asia, Boston Scientific is renowned for its cutting-edge products, such as stents, catheters, and neuromodulation devices. These offerings are distinguished by their advanced technology and commitment to improving patient outcomes. The company has achieved significant milestones, including numerous FDA approvals and recognitions for its contributions to healthcare innovation, solidifying its position as a trusted leader in the medical device sector.
+17 vs industry average
Boston Scientific’s score of 80 is higher than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Boston Scientific?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Electromedical and Electrotherapeutic Apparatus Manufacturing has below-average carbon intensity
Industry performance
The Electromedical and Electrotherapeutic Apparatus Manufacturing industry has increased its overall emissions by 5% since 2019
Emissions trajectory 2020 – 2028
Reported emissions
Scope 3 accounts for ••• of total emissions.
Boston Scientific's reported carbon emissions
Boston Scientific's most recent reported emissions data is for 2025, with Scope 1 and 2 emissions totalling approximately 110.98 million kg CO2e (market-based). In 2024, the company reported total Scope 1 and 2 emissions of approximately 97.42 million kg CO2e (market-based). Scope 3 emissions for 2024 were substantial, reaching approximately 1.66 billion kg CO2e, with purchased goods and services being the largest contributor at approximately 946.98 million kg CO2e.
Boston Scientific is committed to significant climate action. The company has set a near-term target to reduce absolute Scope 1 and 2 greenhouse gas (GHG) emissions by 46.2% by 2030, using 2019 as a baseline year. They also aim for a 55% reduction in Scope 3 GHG emissions per USD value added by 2030 from a 2024 base year.
Looking further ahead, Boston Scientific has a long-term goal to achieve net-zero GHG emissions across its value chain by 2050. This includes a commitment to reduce Scope 1 and 2 GHG emissions by 97% per USD value added (equivalent to a 90% absolute reduction) by 2050, also from a 2019 base year. The company was an early adopter among medical device manufacturers to pledge carbon neutrality by 2030 for its manufacturing and key distribution sites and reports being on track to meet this goal. Their climate strategy is recognised by the Science Based Targets initiative (SBTi) as a critical component of their efforts to improve human health and has approved net-zero, science-based targets.
Unlock detailed emission data
Access structured emission data, company specific factors and auditable source documents
Boston Scientific’s Climate Goals (2030 & 2050)
4 goals2030
46.2% reduction in all scopes
Boston Scientific Limited aims to reduce absolute scope 1 and 2 GHG emissions in the UK by 46.2% by 2030 in alignment with its parent compan…
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
See all 4 climate goals
Already have an account? Sign in now
Scope 3 top emissions categories
12 of 15 categories disclosedSee all scope 3 categories
Already have an account? Sign in now
Climate initiatives

Science Based Targets Initiative

Carbon Disclosure Project
The Climate Pledge
UN Global Compact Climate Champions initiative
RE 100
Climate Action 100
Emissions comparison with industry peers
View similar organisationsFrequently asked questions
Common questions about Boston Scientific’s sustainability data and climate commitments
Data year: 2025
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn moreCurious to see your top suppliers emissions?
Book a demo for a pilot project